The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
GE Healthcare reportedly plans to exit the hospital electronic medical records business.
GE Healthcare (NYSE:GE) reportedly confirmed that it's getting out of the hospital electronic medical records business, aiming for a "graceful transition" for customers using its Centricity Enterprise EMR system.
Here's a look at some of the top legal news stories for medical device companies this week: Appeals court upholds NuVasive patent win over Medtronic; Appeals court won't revisit Bard's $1B win over W.L. Gore; Ex-Boston Scientific engineer cops to stealing catheter secrets; AngioDynamics wants court to enforce $160m Biolitec judgment